WooGene B&G Co., Ltd (KOSDAQ:018620)
South Korea · Delayed Price · Currency is KRW 714.00
+1.00 (0.14%)
At close: Mar 6, 2026
WooGene B&G Market Cap
WooGene B&G has a market cap or net worth of 20.63 billion as of March 6, 2026. Its market cap has decreased by -23.64% in one year.
Market Cap
20.63B
Enterprise Value
72.95B
Revenue
54.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
714.00
Market Cap Chart
Since May 20, 2008, WooGene B&G's market cap has increased from 18.33B to 20.63B, an increase of 12.55%. That is a compound annual growth rate of 0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.63B | -14.08% |
| Dec 30, 2025 | 24.01B | -6.10% |
| Dec 30, 2024 | 25.57B | -27.76% |
| Dec 28, 2023 | 35.39B | -20.45% |
| Dec 29, 2022 | 44.49B | -26.67% |
| Dec 30, 2021 | 60.66B | -23.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 30.72B |
| Hurum | 28.23B |
| Pharmsville | 27.09B |
| ChoA Pharmaceutical Co., LTD. | 26.98B |
| Daesung Microbiological Labs. | 24.09B |
| BIFIDO | 23.27B |
| Union Korea Pharm | 19.70B |
| Kwangdong Healthbio | 18.02B |